GlassScriptPhysician profile
Douglas M Richter
NPI 1346321767
$6,531.53
in general payments reported to CMS, 2019-2025
18 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,392 · 2020: $139 · 2021: $140 · 2022: $384 · 2023: $192 · 2024: $141 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $4,890.59 | 2019 | |
| Janssen Pharmaceuticals, INC | $481.08 | 2019-2024 | Xarelto |
| Amgen INC. | $391.86 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $149.66 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.69 | 2019-2025 | Lifevest |
| Philips North America LLC | $113.35 | 2022-2025 | Mcot, (5050) Extended Holter, (5044) Mcot |
| Pfizer INC. | $66.29 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $57.03 | 2022-2023 | Verquvo, Steglatro, Steglujan |
| E.R. Squibb & Sons, L.L.C. | $54.75 | 2019-2023 | Eliquis |
| W. L. Gore & Associates, INC. | $35.44 | 2022 | |
| Boston Scientific Corporation | $30.89 | 2019 | |
| Atricure, INC. | $26.28 | 2022 | |
| Change Healthcare Technologies, LLC | $25.35 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.32 | 2025 | Entyvio |
| Medtronic, INC. | $18.37 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.92 | 2023 | Jardiance |
| Amneal Pharmaceuticals LLC | $15.35 | 2021 | |
| Astellas Pharma US INC | $14.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Richter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.